These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22934553)

  • 41. Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil.
    Costa WJT; Penha-Silva N; Bezerra IMP; Paulo Dos Santos I; Ramos JLS; Castro JM; Pereira JEG; Silva APD; Monteiro A; de Abreu LC
    Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32545366
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications.
    Kumawat VS; Kaur G
    Eur J Pharmacol; 2019 Nov; 862():172628. PubMed ID: 31461639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toll-like receptors and atherosclerosis: key contributors in disease and health?
    Mullick AE; Tobias PS; Curtiss LK
    Immunol Res; 2006; 34(3):193-209. PubMed ID: 16891671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor.
    Becher PM; Hinrichs S; Fluschnik N; Hennigs JK; Klingel K; Blankenberg S; Westermann D; Lindner D
    PLoS One; 2018; 13(3):e0193844. PubMed ID: 29538462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
    Cole JE; Kassiteridi C; Monaco C
    Trends Pharmacol Sci; 2013 Nov; 34(11):629-36. PubMed ID: 24139612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TLR signalling and association of TLR polymorphism with cardiovascular diseases.
    Sharma S; Garg I; Ashraf MZ
    Vascul Pharmacol; 2016 Dec; 87():30-37. PubMed ID: 27826031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.
    Berlanga-Acosta J; Schultz GS; López-Mola E; Guillen-Nieto G; García-Siverio M; Herrera-Martínez L
    Biomed Res Int; 2013; 2013():256043. PubMed ID: 23484099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toll-like receptors in angiogenesis.
    Grote K; Schütt H; Schieffer B
    ScientificWorldJournal; 2011 Apr; 11():981-91. PubMed ID: 21516292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection.
    Hamed SA; Amine NF; Galal GM; Helal SR; Tag El-Din LM; Shawky OA; Ahmed EA; Abdel Rahman MS
    J Stroke Cerebrovasc Dis; 2008; 17(2):86-94. PubMed ID: 18346651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
    Cole JE; Mitra AT; Monaco C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toll-like receptors and macrophage activation in atherosclerosis.
    Seneviratne AN; Sivagurunathan B; Monaco C
    Clin Chim Acta; 2012 Jan; 413(1-2):3-14. PubMed ID: 21884686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diabetes, a public health problem. The epidemiology of sugar diabetes and its long term complications].
    Ekoé JM; Emond V; Huot C
    Perspect Infirm; 2006; 4(2):10-6. PubMed ID: 17184091
    [No Abstract]   [Full Text] [Related]  

  • 54. Introduction to diabetes mellitus.
    Kaul K; Tarr JM; Ahmad SI; Kohner EM; Chibber R
    Adv Exp Med Biol; 2012; 771():1-11. PubMed ID: 23393665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities.
    Ozdemir D; Feinberg MW
    Trends Cardiovasc Med; 2019 Apr; 29(3):131-137. PubMed ID: 30143275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postpartum Readmissions Among Women With Diabetes.
    Mourad M; Wen T; Friedman AM; Lonier JY; D'Alton ME; Zork N
    Obstet Gynecol; 2020 Jan; 135(1):80-89. PubMed ID: 31809421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.
    Xu M; Li N; Fan X; Zhou Y; Bi S; Shen A; Wang B
    Microbiol Spectr; 2022 Feb; 10(1):e0114421. PubMed ID: 35196817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity.
    Parker LC; Prince LR; Sabroe I
    Clin Exp Immunol; 2007 Feb; 147(2):199-207. PubMed ID: 17223959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptors: sensing and reacting to diabetic injury in the kidney.
    Lin M; Tang SC
    Nephrol Dial Transplant; 2014 Apr; 29(4):746-54. PubMed ID: 24203812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of endosomal members of toll-like receptor family abrogates wound healing in patients with type 2 diabetes mellitus.
    Singh K; Agrawal NK; Gupta SK; Mohan G; Chaturvedi S; Singh K
    Int Wound J; 2016 Oct; 13(5):927-35. PubMed ID: 25586463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.